Regulation of cyclin-dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage-induced neuronal death
SCIE
SCOPUS
- Title
- Regulation of cyclin-dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage-induced neuronal death
- Authors
- Lee, JH; Kim, KT
- Date Issued
- 2007-03
- Publisher
- WILEY-LISS
- Abstract
- DNA damage is known to be an initiator of neuronal death in neurodegenerative conditions such as Parkinson's and Alzheimer's diseases. The mechanism linking DNA damage and neuronal death is not completely understood. Here, we delineate the mechanism by which neuronal death evoked by DNA damage is controlled. Using mouse cortical neurons and SH-SY5Y human neuroblastoma cells, we identify a critical role of ERK signaling in neuronal death induced by DNA damage upon mitomycin C treatment. In addition, we provide evidence that the ERK signaling regulates Cyclin-dependent kinase 5 (Cdk5) activity and stability of tumor suppressor p53. Mitomycin C increased expression of p35, a specific activator of neuronal Cdk5 in an ERK1/2-dependent manner. Moreover, stability of p53 was increased by its phosphorylation on Ser33 and Ser46 by Cdk5, leading to neuronal death. Finally, we show that activated ERK induced increased expression of the Egr-1 transcription factor, which then bound to the promoter region of p35. We suggest subsequent increase of p35 expression and Cdk5 activity contribute to p53-dependent neuronal death. Thus, the present finding provides a new insight into a molecular mechanism underlying DNA damage-induced neuronal death.
- Keywords
- ACTIVATED PROTEIN-KINASE; CELL-DEATH; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; P35; APOPTOSIS; CDK5; INDUCTION
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/23594
- DOI
- 10.1002/JCP.20899
- ISSN
- 0021-9541
- Article Type
- Article
- Citation
- JOURNAL OF CELLULAR PHYSIOLOGY, vol. 210, no. 3, page. 784 - 797, 2007-03
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.